|
|
Volumn 92, Issue 8, 2014, Pages e697-e698
|
|
Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration
a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
RANIBIZUMAB;
VASCULOTROPIN A;
VEGFA PROTEIN, HUMAN;
AGED;
ANTAGONISTS AND INHIBITORS;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
RECURRENT DISEASE;
RETROSPECTIVE STUDY;
TREATMENT WITHDRAWAL;
VERY ELDERLY;
WET MACULAR DEGENERATION;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
RECURRENCE;
RETROSPECTIVE STUDIES;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
WET MACULAR DEGENERATION;
WITHHOLDING TREATMENT;
|
|
EID: 85027954745
PISSN: None
EISSN: 17553768
Source Type: Journal
DOI: 10.1111/aos.12417 Document Type: Letter |
|
Times cited : (14)
|
|
References (0)
|